Avidity Partners Management LP Invests $5.65 Million in Agilent Technologies, Inc. $A

Posted by Brenda Bartman on Jun 14th, 2026

Avidity Partners Management LP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 41,500 shares of the medical research company’s stock, valued at approximately $5,647,000. Agilent Technologies makes up 1.6% of Avidity Partners Management LP’s holdings, making the stock its 14th largest position.

A number of other large investors have also modified their holdings of A. Norges Bank purchased a new position in shares of Agilent Technologies during the 4th quarter worth approximately $549,158,000. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. raised its stake in shares of Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of Agilent Technologies by 42.0% during the 4th quarter. Bank of New York Mellon Corp now owns 2,857,820 shares of the medical research company’s stock worth $388,864,000 after buying an additional 845,688 shares in the last quarter.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $129.76 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a fifty day moving average of $120.24 and a two-hundred day moving average of $127.86. The company has a market capitalization of $36.65 billion, a price-to-earnings ratio of 26.06, a PEG ratio of 2.31 and a beta of 1.26. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The company had revenue of $1.84 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on A. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Morgan Stanley cut their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and cut their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Robert W. Baird raised their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $160.93.

Check Out Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.